GSK Plc (GSK)
54.52
-0.76
(-1.37%)
USD |
NYSE |
Mar 06, 16:00
54.50
-0.02
(-0.03%)
After-Hours: 20:00
GSK Cash from Investing (TTM) : -7.740B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| AstraZeneca PLC | -7.111B |
| Biodexa Pharmaceuticals Plc | -0.4065M |
| Mereo BioPharma Group Plc | -0.0172M |
| Rapt Therapeutics, Inc. | -56.70M |
| Moderna, Inc. | 1.946B |